Changes in ultrasound findings in posterior uveal melanoma after Ruthenium 106 brachytherapy

Igor Kaiserman*, Irene Anteby, Itay Chowers, Eytan Z. Blumenthal, Iris Kliers, Jacob Pe'er

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Purpose: To analyze the postbrachytherapy ultrasonographic dynamics of uveal melanoma tumor height and internal reflectivity. Design: Prospective, comparative, observational case series. Participants: One hundred forty-seven patients (147 eyes) with posterior uveal melanoma having a mean age of 61 years (range, 29-97 years) who were treated with Ruthenium 106 brachytherapy. Methods: Patients were followed-up with ultrasonography using both A and B modes of standardized echography every 6.7 ± 0.3 months (mean ± standard error of the mean) for a total of 1001 ultrasound examinations. On average, each patient was examined 5.8 times (range, 3-17 times). The echographic parameters included tumor base size, height, internal reflectivity, regularity, vascularity, and extra-scleral extension. To compare the response of tumors of different sizes, each tumor was standardized to its initial size at brachytherapy. Main Outcome Measures: The dynamics of the tumor height and internal reflectivity. Results: At the time of brachytherapy, the mean height of the tumors was 5.2 mm (range, 2.2-11.8 mm). After brachytherapy, 142 tumors (96.6%) responded by a decrease in height. The decrease in height was at an initial rate of approximately 3% per month. Most of the tumors did not regress entirely; rather, their height stabilized on a constant value (on average 61% of the initial height) after approximately 18 to 24 months. The decrease in height after brachytherapy was best fitted by the sum of a first order exponential decay and a constant (h = 61 + 35*e-0.12t, in which t = time in months). The half-life of the decay was 5.8 months. Large tumors (>8 mm) had a faster initial decrease in height, and stabilized on a lower percentage of their initial height (50%) compared with small tumors (70%). Thus, the half-life of the height exponential decay was 5.3 months for small tumors (2-4 mm) and 3.3 months for the large tumors (>8 mm). Internal reflectivity increased from a mean of 40% before therapy to 70% after 2 years. The dynamics of the reflectivity were best fitted with the function: f = 45 + 24(1-e-0.09t). Larger tumors, which initially had lower internal reflectivity, presented with a slower increase in internal reflectivity (t1/2 = 8.7 months) compared with smaller tumors (t1/2 = 5 months). Conclusions: The postbrachytherapy ultrasonographic dynamics of uveal melanomas resemble a function composed of the sum of a constant and a first order exponent, suggesting the possible existence of two components (cell populations), one unaffected by brachytherapy and the other a radiosensitive population that reacts to brachytherapy in an exponential decay. An exponential decay can imply that the postbrachytherapy death of each tumor cell is a stochastic Markovian process that is independent of the death of other tumor cells.

Original languageAmerican English
Pages (from-to)1137-1141
Number of pages5
Issue number6
StatePublished - 2002
Externally publishedYes


Dive into the research topics of 'Changes in ultrasound findings in posterior uveal melanoma after Ruthenium 106 brachytherapy'. Together they form a unique fingerprint.

Cite this